Icecure Medical FY EPS $(0.32), Inline, Sales $3.23M Beat $3.14M Estimate
Icecure Medical FY EPS $(0.32), Inline, Sales $3.23M Beat $3.14M Estimate
Icecure Medical財年每股收益爲0.32美元（0.32美元），同比增長，銷售額爲323萬美元，超過預期的314萬美元
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 30.43 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $3.23 million which beat the analyst consensus estimate of $3.14 million by 2.83 percent. This is a 4.67 percent increase over sales of $3.08 million the same period last year.
Icecure Medical（納斯達克股票代碼：ICCM）公佈的季度虧損爲每股0.32美元，符合分析師的共識預期。與去年同期每股虧損0.46美元（0.46美元）相比，增長了30.43％。該公司公佈的季度銷售額爲323萬美元，比分析師普遍預期的314萬美元高出2.83％。這比去年同期的308萬美元銷售額增長了4.67％。